www.fdanews.com/articles/62531-pharma-blog-watch
Pharma Blog Watch
September 14, 2006
Letters from Congress
(Eye on FDA)
In his blog, Mark Senak discusses what he sees as a growing tendency among lawmakers
to send letters to the FDA requesting action, citing in particular a recent
one from Rep. Henry Waxman (D-Calif.) asking for an investigation of nasal decongestants.
"Put all the letters from individual Congresspeople together in a bundle
and what you get is micromanagement," he writes.